This inventor holds 1 USPTO granted patent. Top assignee: Institut Pasteur. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Bridgitte Gicquel: Innovator in Immunology
Introduction
Bridgitte Gicquel is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology through her innovative research and inventions. Her work focuses on developing recombinant mycobacteria that can serve as immunogens or vaccine components.
Latest Patents
Bridgitte Gicquel holds a patent for her invention titled "Attenuated recombinant mycobacteria useful as immunogens or as vaccine components." This invention provides recombinant mycobacterium strains of pathogenic origin that have been attenuated by the inactivation of a gene coding for a metabolic protein. Specifically, it targets the purC gene, which codes for an enzyme necessary for the biosynthesis of purine. The recombinant mycobacterium developed through this invention has a reduced capacity to propagate in a mammalian host while remaining viable long enough to induce a protective immune response against its natural pathogenic counterpart. She has 1 patent to her name.
Career Highlights
Bridgitte Gicquel is affiliated with the prestigious Institut Pasteur, where she conducts her research. Her work has garnered attention for its potential applications in vaccine development and immunotherapy.
Collaborations
Throughout her career, Bridgitte has collaborated with notable colleagues, including Christophe Guilhot and Mary Jackson. These collaborations have further enhanced her research and contributed to advancements in the field.
Conclusion
Bridgitte Gicquel is a trailblazer in the field of immunology, with her innovative patent paving the way for future vaccine development. Her contributions continue to impact the scientific community and public health positively.